This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kunicki, T. J. Search for Related Content PubMed PubMed Citation Articles by Kunicki, T. J. Pubmed/NCBI databases Substance via MeSH Related Collections Arterial thrombosis Thrombosis risk factors Platelets

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:14.)
© 2002 American Heart Association, Inc.

Brief Reviews

The Influence of Platelet Collagen Receptor Polymorphisms in Hemostasis and Thrombotic Disease

Thomas J. Kunicki

From The Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis of the Department of Molecular and Experimental Medicine and the Department of Vascular Biology, The Scripps Research Institute, La Jolla, Calif.

Address correspondence to Thomas J. Kunicki, PhD, Associate Professor, Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 N Torrey Pines Rd, Maildrop: MEM 150, La Jolla, CA 92037. E-mail tomk{at}scripps.edu

Extracellular collagens modulate the rate of platelet activation and thereby markedly influence hemostasis and thrombosis. Platelet receptors for collagens, such as the integrin ₂ß₁, platelet glycoprotein (GP) VI or, indirectly, the GPIb complex, are unexploited targets of pharmacological control, and polymorphisms of these receptors have recently become factored into the genetic risk for thrombosis. Seemingly contradictory findings already exist with regard to the contribution of GPIb and integrin ₂ polymorphisms, but these discrepancies will be resolved once there is better standardization of clinical studies. There is already substantial evidence that GPIb VNTR A or B alleles, the GPIb-5C allele, and integrin ₂ allele 1 (T₈₀₇) each contribute to increased risk for morbidity in thrombotic disease. However, larger, prospective genetic and epidemiological studies are needed to clarify the role of each of these polymorphisms, the contribution of other platelet receptor polymorphisms, and the synergistic effects of combinations of these factors. In addition, in vitro studies that establish the functional relevance of these polymorphisms will provide sound biological explanations for the results of clinical correlation studies.

Key Words: platelet • collagen • integrin • GPVI • thrombosis

This article has been cited by other articles:

				J. P. Corsetti, D. Ryan, A. J. Moss, D. L. Rainwater, W. Zareba, and C. E. Sparks Glycoprotein Ib{alpha} Polymorphism T145M, Elevated Lipoprotein-Associated Phospholipase A2, and Hypertriglyceridemia Predict Risk for Recurrent Coronary Events in Diabetic Postinfarction Patients Diabetes, May 1, 2007; 56(5): 1429 - 1435. [Abstract] [Full Text] [PDF]

				L. Navarro-Nunez, M. L. Lozano, J. Rivera, J. Corral, V. Roldan, R. Gonzalez-Conejero, J. A. Iniesta, J. Montaner, V. Vicente, and C. Martinez The association of the {beta}1-tubulin Q43P polymorphism with intracerebral hemorrhage in men Haematologica, April 1, 2007; 92(4): 513 - 518. [Abstract] [Full Text] [PDF]

				M. Ogino, J. Kido, M. Bando, N. Hayashi, C. Wada, T. Nagata, F. Nishimura, Y. Soga, S. Takashiba, T. Kubota, et al. {alpha}2 Integrin +807 Polymorphism in Drug-induced Gingival Overgrowth J. Dent. Res., December 1, 2005; 84(12): 1183 - 1186. [Abstract] [Full Text] [PDF]

				T. J. Kunicki, A. B. Federici, D. R. Salomon, J. A. Koziol, S. R. Head, T. S. Mondala, J. D. Chismar, L. Baronciani, M. T. Canciani, and I. R. Peake An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees Blood, October 15, 2004; 104(8): 2359 - 2367. [Abstract] [Full Text] [PDF]

				M. J. Coffey, G. E. Jarvis, J. M. Gibbins, B. Coles, N. E. Barrett, O. R.E. Wylie, and V. B. O'Donnell Platelet 12-Lipoxygenase Activation via Glycoprotein VI: Involvement of Multiple Signaling Pathways in Agonist Control of H(P)ETE Synthesis Circ. Res., June 25, 2004; 94(12): 1598 - 1605. [Abstract] [Full Text] [PDF]

				Z. Wang, T. M. Leisner, and L. V. Parise Platelet {alpha}2{beta}1 integrin activation: contribution of ligand internalization and the {alpha}2-cytoplasmic domain Blood, August 15, 2003; 102(4): 1307 - 1315. [Abstract] [Full Text] [PDF]

				O. Inoue, K. Suzuki-Inoue, W. L. Dean, J. Frampton, and S. P. Watson Integrin {alpha}2{beta}1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLC{gamma}2 J. Cell Biol., March 3, 2003; 160(5): 769 - 780. [Abstract] [Full Text] [PDF]

				A. Dupont, P. Fontana, C. Bachelot-Loza, J.-L. Reny, I. Bieche, F. Desvard, M. Aiach, and P. Gaussem An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN Blood, March 1, 2003; 101(5): 1833 - 1840. [Abstract] [Full Text] [PDF]

				K. Furihata and T. J. Kunicki Characterization of Human Glycoprotein VI Gene 5' Regulatory and Promoter Regions Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1733 - 1739. [Abstract] [Full Text] [PDF]